Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia

This study has been withdrawn prior to enrollment.
(Withdrawn for administrative reasons.)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT01180764
First received: May 17, 2010
Last updated: February 4, 2016
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)